FDA
-
-
-
-
-
-
-
US FDA approves Johnson & Johnson's blood cancer therapy
-
-
-
-
-
-
-
US FDA revokes emergency use authorization for J&J's COVID vaccine
-
-
-
-
-
-
-
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
-
-
-
-
-
-
-
Janssen (JNJ) Announces U.S. FDA Approves TECVAYLI, the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
-
-
-
-
-
-
-
Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology
-
-
-
-
-
-
-
Novavax's COVID-19 Vaccine Wins FDA AdCom Blessing, Removing 'Major Overhang'
-
-
-
-
-
-
-
Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen - World's First and Only Drug-Eluting Contact Lens
-
240,152 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All